 reuters    democratic senators questioned president donald trump s nominee to lead the u s  food and drug administration  dr  scott gottlieb  over his ties to the pharmaceutical industry on wednesday  with one citing  a level of discomfort  over his nomination  democrats on the senate committee on health  education  labor and pensions questioned whether gottlieb s ties to the pharmaceutical industry would compromise his ability to act impartially  ahead of a vote on whether to advance his nomination to the full senate  gottlieb  a former fda deputy commission who is a partner at a large venture capital fund and sits on the boards of multiple healthcare companies  has advocated loosening requirements needed for approval of new medical products  his nomination is generally expected to be approved  the hearing also covered gottlieb s views on issues ranging from clinical trials to the opioid epidemic and vaccines  senator chris murphy said democrats had  a level of discomfort  with gottlieb s nomination  not just because of his private industry background but also because of his prior activity as a political adviser to republican presidential candidates and opposition to the affordable care act   the worry about impartiality is certainly connected to the private sector experience but it s also to your very deep political involvement as well   murphy said  gottlieb    acknowledged the concern  but said he would  work hard to make sure i preserve my impartiality   in an ethics disclosure form filed last month gottlieb said he would resign from multiple corporate boards and divest his healthcare company holdings  republicans on the committee said gottlieb s background would provide him with valuable insight into the industry that the fda regulates  gottlieb said his goal was to implement the provisions in the recently passed  century cures act that among other things require the fda to consider ways to streamline the clinical trial process  he said he would be in favor of  clinical trial constructs that don t require the tight randomization that current clinical trials do   gottlieb also said he would be willing to challenge the view that vaccines cause autism  a theory that has been widely debunked by vaccine experts  in january trump s transition team floated the idea of forming a panel on autism  in  trump said in a tweet that he believed in vaccinations  but not massive  all at once  shots  and that  govt  should stop now   gottlieb said the question of whether vaccines cause autism  is one of the most exhaustively studied issues in medicine  and that there is no causal link between vaccines and autism  pressed on whether he would challenge contrary views  gottlieb said he has a history  of not being shy about speaking truth to power and making my views known   gottlieb called the opioid epidemic  a public health emergency on the order of ebola and zika   he said it is the biggest health crisis facing the fda and that solving the problem would require a broad public health response  gottlieb  who held a financial interest in the vape shop kure  said some e cigarettes may have the potential to wean smokers off combustible cigarettes and be less harmful   an e cigarette or vaping product might be a good smoking cessation tool while a chocolate chip flavored e cigarette might not be   he said  ultimately  he said  science will tell where to draw that line  